Cargando…

SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring

Detalles Bibliográficos
Autores principales: Kirschbaum, Klara, Vasa-Nicotera, Mariuca, Zeiher, Andreas Michael, Cremer, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971173/
https://www.ncbi.nlm.nih.gov/pubmed/34689229
http://dx.doi.org/10.1007/s00392-021-01954-4
_version_ 1784679588080648192
author Kirschbaum, Klara
Vasa-Nicotera, Mariuca
Zeiher, Andreas Michael
Cremer, Sebastian
author_facet Kirschbaum, Klara
Vasa-Nicotera, Mariuca
Zeiher, Andreas Michael
Cremer, Sebastian
author_sort Kirschbaum, Klara
collection PubMed
description
format Online
Article
Text
id pubmed-8971173
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89711732022-04-07 SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring Kirschbaum, Klara Vasa-Nicotera, Mariuca Zeiher, Andreas Michael Cremer, Sebastian Clin Res Cardiol Letter to the Editors Springer Berlin Heidelberg 2021-10-24 2022 /pmc/articles/PMC8971173/ /pubmed/34689229 http://dx.doi.org/10.1007/s00392-021-01954-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editors
Kirschbaum, Klara
Vasa-Nicotera, Mariuca
Zeiher, Andreas Michael
Cremer, Sebastian
SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title_full SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title_fullStr SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title_full_unstemmed SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title_short SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
title_sort sglt2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971173/
https://www.ncbi.nlm.nih.gov/pubmed/34689229
http://dx.doi.org/10.1007/s00392-021-01954-4
work_keys_str_mv AT kirschbaumklara sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring
AT vasanicoteramariuca sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring
AT zeiherandreasmichael sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring
AT cremersebastian sglt2inhibitortherapyandpulmonaryarterypressureinpatientswithchronicheartfailurefurtherevidenceforimprovedhemodynamicsbycontinuouspressuremonitoring